Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
NEVRO CORP (NVRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2022 8-K Quarterly results
Docs: "Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance"
05/04/2022 8-K Quarterly results
02/23/2022 8-K Quarterly results
Docs: "Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance"
11/08/2021 8-K Quarterly results
Docs: "Vice President, Investor Relations"
08/04/2021 8-K Quarterly results
07/19/2021 8-K Quarterly results
Docs: "www.HFXforPDN.com"
05/05/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Nevro Corp. Consolidated Statements of Operations and Comprehensive Loss Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019"
08/05/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
02/25/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
Docs: "Nevro Reports Third Quarter 2019 Financial Results Company Raises 2019 Guidance, Announces CFO Retirement Plans"
08/08/2019 8-K Quarterly results
Docs: "Nevro Reports Second Quarter 2019 Financial Results"
02/21/2019 8-K Quarterly results
05/07/2018 8-K Quarterly results
Docs: "Nevro Corp. Consolidated Statements of Operations and Comprehensive Loss Three Months Ended March 31, 2018 2017"
11/06/2017 8-K Quarterly results
Docs: "Nevro Corp. Consolidated Statements of Operations and Comprehensive Loss Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016"
08/07/2017 8-K Quarterly results
05/08/2017 8-K Form 8-K - Current report
11/07/2016 8-K Quarterly results
Docs: "Nevro Corp. Consolidated Statements of Operations and Comprehensive Loss Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015"
08/08/2016 8-K Form 8-K - Current report
05/09/2016 8-K Form 8-K - Current report
11/09/2015 8-K Quarterly results
Docs: "Nevro Corp. Consolidated Statements of Comprehensive Loss Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Revenue $ 15,402 $ 8,668 $ 36,482 $ 22,858 Cost of revenue 5,968 2,737 15,349 8,257 Gross profit 9,434 5,931 21,133 14,601 Operating expenses: Research and development 5,247 5,236 15,508 15,082 Sales, general and administrative 21,896 7,193 54,848 20,719 Total operating expenses 27,143 12,429 70,356 35,801 Loss from operations Other income : Interest income , net 20 93 Other income , net Loss before income taxes Provision for income taxes 269 137 566 374 Net loss Accretion of convertible preferred stock to redemption value — — Net loss attributable to common stockholders Changes in foreign currency translation adjustment Changes in gains..."
08/06/2015 8-K Quarterly results
Docs: "Recent Accomplishments & Highlights:"
05/11/2015 8-K Quarterly results
Docs: "Recent Accomplishments & Highlights:",
"Nevro Receives FDA Approval for Senza ® Spinal Cord Stimulation System Delivering HF10™ Therapy"
12/02/2014 8-K Quarterly results
Docs: "Nevro Reports Third Quarter Financial Results Menlo Park, Calif., December 2, 2014 - Nevro Corp. , a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today reported financial results for the three and nine months ended September 30, 2014. Recent Accomplishments & Highlights:"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy